Literature DB >> 2645186

Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events.

J N Clore1, J E Nestler, W G Blackard.   

Abstract

Values reported for basal hepatic glucose production and glucose utilization do not reflect metabolic changes occurring during sleep. To determine the effect of sleep with its associated lowered metabolic rate and thermogenesis on glucose kinetics and gluconeogenic substrate availability, 11 normal volunteers underwent an overnight study in which [3-3H]glucose was infused. Despite decreased insulin secretion, a fall in hepatic glucose output was observed with sleep that was synchronous with a reduction in glucose utilization and lipolysis (decreased plasma glycerol and free fatty acids). When activity was increased, these parameters rose toward previously reported basal levels. Prevention of sleep in 6 additional subjects attenuated the fall in glucose utilization and production as well as the fall in glycerol and free fatty acids despite similar insulin and counterregulatory hormone profiles. We suggest that sleep-associated metabolic changes produce a peripheral signal(s) that modulates hepatic glucose production in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645186     DOI: 10.2337/diab.38.3.285

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Metabolic Effects of Late Dinner in Healthy Volunteers-A Randomized Crossover Clinical Trial.

Authors:  Chenjuan Gu; Nga Brereton; Amy Schweitzer; Matthew Cotter; Daisy Duan; Elisabet Børsheim; Robert R Wolfe; Luu V Pham; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

2.  Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance.

Authors:  Arlet V Nedeltcheva; Lynn Kessler; Jacqueline Imperial; Plamen D Penev
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

3.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 4.  Sleep disorders and the development of insulin resistance and obesity.

Authors:  Omar Mesarwi; Jan Polak; Jonathan Jun; Vsevolod Y Polotsky
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

5.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

6.  Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep.

Authors:  Swati Chopra; Aman Rathore; Haris Younas; Luu V Pham; Chenjuan Gu; Aleksandra Beselman; Il-Young Kim; Robert R Wolfe; Jamie Perin; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 7.  Circadian rhythms, diet, and neuronal excitability.

Authors:  Charles N Allen
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

8.  Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.

Authors:  E Van Cauter; J D Blackman; D Roland; J P Spire; S Refetoff; K S Polonsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 9.  Basal insulin therapy.

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

Review 10.  Which basal insulin should be used in patients with type 2 diabetes mellitus?

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2007-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.